Clinical Trials
| Cancer Type: Breast | |
| Description: Cyclophosphamide and Doxorubicin (CA) (4 vs. 6 Cycles) Versus Paclitaxel (4 vs. 6 Cycles) as Adjuvant Therapy for Breast Cancer in Women with 0-3 Positive Axillary Lymph Nodes: A 2X2 Factorial Phase III Randomized Study |
|
| Entity Approving The Trial: Cancer and Leukemia Group B (CALGB) |
|
| Phase: III | |
| Site-Wide Accrual Goal: 4,646 | |
| Related Files | |
| No related files found. | |
| Related Links | |
| http://www.cancer.gov/search/viewclinicaltrials.aspx?version=healthprofessional&cdrid=69444 |
 |
 |
|
